UCSF Opens World’s First Center of Excellence for Gould Syndrome
UCSF is home to the first center in the world focused on patients with COL4A1/2 mutations, which can cause the rare disease Gould Syndrome.
University of California San Francisco
Give to UCSFUCSF is home to the first center in the world focused on patients with COL4A1/2 mutations, which can cause the rare disease Gould Syndrome.
UCSF has been honored as a Top Producing Institution for Fulbright U.S. Students by the U.S. State Department for the 2023-2024 academic year.
California’s trailblazing surgeon general is using her platform to pave the way for improving the health of women, children and communities of color while inspiring a new generation of Latinx physicians.
UCSF Health, Adventist Health and Madera County leaders announced their intent to jointly reopen and operate Madera Community Hospital.
The two-year HEAL fellowship initiative operates in 10 countries but has a special focus on serving the Navajo Nation, which continues to suffer from the consequences of colonialism, including poor access to health care.
Nicholas Holmes, MD, MBA, was named the new president of UCSF Benioff Children’s Hospitals and senior vice president of UCSF Health Children’s Services.
Combining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better than treatment with a single drug.
Andrea V. Jackson, MD, MAS, a highly regarded obstetrician, gynecologist and diversity champion, has been appointed chair of the UCSF Department of Obstetrics, Gynecology & Reproductive Sciences.
Early identification of posterior cortical atrophy (PCA) may have important implications for Alzheimer’s treatment. PCA patients struggle with visual impairments like judging distances, distinguishing between moving and stationary objects and completing tasks like writing and retrieving a dropped item.
The Danaher-IGI Beacon for CRISPR Cures center will use genome editing to address potentially hundreds of diseases, including rare genetic disorders that have no cure, to ensure treatments can be developed and brought to patients more quickly and efficiently.
A study of seriously ill patients from academic medical centers across the country has found that nearly a quarter had a delayed or missed diagnosis.
Many physicians are unfamiliar with how the Food and Drug Administration’s (FDA) regulates new drugs and medical devices, and they may be under the impression that the data supporting these approvals
UC San Francisco’s Thomas G. Martin, MD, a leading expert in blood cancers, has received a grant of nearly $4.6 million from the California Institute of Regenerative Medicine (CIRM) to produce a CAR T
A team of researchers from UC San Francisco has found that Paxlovid did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection.
C. Benjamin Ma, MD, a highly regarded orthopaedic surgeon and advanced imaging researcher, has been appointed as chair of the UCSF Department of Orthopaedic Surgery. Ma will assume his new role on Jan